Does Fatty Liver Cause Dark Circles Under Eyes?

Does fatty liver cause dark circles under the eyes? It is a question many people ask, but the short answer is that there is no established direct link between the two. Fatty liver disease, or hepatic steatosis, is often entirely silent in its early stages and does not appear on NHS or NICE clinical lists as a cause of periorbital darkening. That said, shared underlying factors such as fatigue, poor sleep and metabolic conditions can make both more likely to occur together. This article explains what the evidence does and does not show, what liver disease can do to your skin, and when it is worth speaking to your GP.

Can a fatty liver actually cause dark circles under your eyes?

There is no established direct causal link between fatty liver disease and dark circles under the eyes; dark circles are not a recognised symptom in NHS or NICE clinical guidance for this condition.

There is no established, direct causal link between fatty liver disease and dark circles under the eyes, though the two can sometimes coexist through shared underlying factors. Fatty liver disease, known medically as hepatic steatosis, is a condition in which excess fat accumulates within liver cells. In its early stages it is often entirely silent, producing no outward signs at all.

When liver disease progresses to more advanced stages, such as cirrhosis or significant liver inflammation, it can affect the body's ability to process nutrients, regulate hormones and clear waste products from the blood. These systemic effects can contribute to a generally fatigued or unwell appearance. The well-recognised visible signs of advanced liver disease include jaundice (yellowing of the skin and eyes), spider naevi and palmar erythema; a specific effect on the skin around the eyes is not among them.

Dark circles are not listed as a recognised symptom of fatty liver disease in NHS or NICE clinical guidance (NICE NG49).^[1][2] If you are concerned about both your liver health and changes to your appearance, speaking to your GP is the most appropriate first step.

How does liver disease affect your skin and appearance?

Advanced liver disease can cause jaundice, spider naevi, palmar erythema and easy bruising, but these changes appear only with significant liver damage, not in early fatty liver disease.

Advanced liver disease can produce a range of visible skin changes, though most of these appear only when the liver is significantly damaged rather than in early fatty liver disease. One of the most recognisable signs is jaundice, a yellowing of the skin and whites of the eyes caused by a build-up of bilirubin, a pigment the liver normally processes and excretes.^[6]

Other skin changes associated with chronic liver disease include:

• Cholestasis-related pruritus (persistent itching): itching associated with impaired bile flow is multifactorial and not fully understood; it is a feature of more advanced or cholestatic liver disease

• Spider naevi: small, spider-shaped blood vessels visible on the skin, particularly on the chest and face

• Palmar erythema: redness of the palms of the hands

• Bruising easily: because a damaged liver produces fewer clotting proteins

• Xanthelasma: yellowish deposits around the eyelids, most directly linked to dyslipidaemia; these can occur in people with metabolic syndrome, which sometimes accompanies fatty liver disease^[10][11]

Generalised fatigue and poor sleep, which are common in people with liver conditions, can also contribute to a washed-out or shadowed appearance around the eyes. However, these are indirect effects rather than a direct consequence of liver dysfunction acting on the periorbital skin. Most early-stage fatty liver disease produces none of these changes at all.

What other symptoms suggest your liver may not be working properly?

Early fatty liver disease usually causes no symptoms; warning signs of more advanced disease include persistent fatigue, upper right abdominal discomfort, pale stools, dark urine and jaundice.

Fatty liver disease in its early stages (simple steatosis) typically causes no symptoms, which is why it is often discovered incidentally during an ultrasound or blood test carried out for another reason. When the liver becomes inflamed, a condition called metabolic dysfunction-associated steatohepatitis (MASH, previously known as NASH), symptoms may begin to emerge.^[12][13]

Symptoms that can suggest the liver is under strain include:

• Persistent fatigue that is disproportionate to activity levels

• Discomfort or a dull ache in the upper right abdomen, where the liver sits

• Unexplained weight loss

• Nausea or a reduced appetite

• Pale stools or dark urine, which can indicate impaired bile flow (cholestasis)

• Abdominal swelling (ascites) in more advanced disease

• Confusion or difficulty concentrating (hepatic encephalopathy) in severe cases

If liver disease progresses to cirrhosis, more serious signs can develop, including significant jaundice, swollen legs and ankles, and vomiting blood. If you experience sudden, severe abdominal pain, vomiting blood, or significant confusion, call 999 or attend A&E immediately, as these can indicate a serious and potentially life-threatening liver complication.

It is worth noting that many of these symptoms are non-specific and can be caused by a wide range of conditions. Only appropriate clinical assessment and investigation can determine whether the liver is involved.

What else commonly causes dark circles under the eyes?

Dark circles are most commonly caused by genetics, poor sleep, ageing, allergies, dehydration or anaemia, and in the vast majority of cases are unrelated to liver disease.

Dark circles under the eyes are extremely common and, in the vast majority of cases, are unrelated to liver disease. Understanding the more frequent causes can help put any concerns into perspective.

The most common causes include:

• Genetics and skin tone: Periorbital hyperpigmentation can run in families and is more visible in people with darker skin tones due to increased melanin in the under-eye area

• Fatigue and poor sleep: Lack of sleep causes blood vessels beneath the thin under-eye skin to dilate, creating a darker appearance

• Ageing: The skin around the eyes thins with age, making underlying blood vessels more visible

• Allergies and hay fever: Allergic rhinitis causes nasal congestion, which can dilate and darken the veins draining from the eyes

• Dehydration: Reduced fluid intake can make the skin appear dull and sunken

• Anaemia: Iron deficiency can cause pallor and fatigue; in some people this may contribute to a shadowed appearance around the eyes, though a GP review is advisable if you suspect anaemia

• Excessive sun exposure: UV exposure can stimulate melanin production in the periorbital area

In most people, dark circles are a cosmetic concern rather than a sign of underlying illness. However, if they appear suddenly alongside other symptoms, a GP review is sensible.

When should you see a GP about dark circles and liver concerns?

See a GP if dark circles are accompanied by jaundice, unexplained weight loss, abdominal swelling or persistent fatigue; call 999 immediately for sudden severe abdominal pain or vomiting blood.

You should see your GP about dark circles if they appear suddenly, are worsening, or are accompanied by other symptoms that suggest an underlying health condition. Dark circles alone, particularly if they have been present for years or run in your family, are unlikely to require urgent investigation.

Seek a GP appointment if you notice dark circles alongside any of the following:

• Persistent fatigue that does not improve with rest

• Yellowing of the skin or eyes (jaundice)

• Unexplained weight loss

• Persistent upper abdominal discomfort

• Pale stools or dark urine

• Swelling of the abdomen or legs

• Itching without an obvious cause

• A known risk factor for fatty liver disease, such as obesity, type 2 diabetes, or high cholesterol

Call 999 or attend A&E immediately if you experience sudden severe abdominal pain, vomiting blood, or severe acute confusion, as these can indicate a serious liver complication requiring emergency assessment. Contact NHS 111 if you are concerned but your symptoms are not immediately life-threatening and you are unable to reach your GP.

For most people, a GP will take a history, examine you, and may arrange blood tests including liver function tests (LFTs) if there is clinical reason to do so. There is no need to attend A&E for dark circles alone, even if you are worried about your liver.

How is fatty liver diagnosed and managed on the NHS?

Fatty liver is diagnosed with liver function tests, abdominal ultrasound and non-invasive fibrosis scoring tools per NICE NG49; management centres on weight loss, diet, exercise and control of metabolic risk factors.

Fatty liver disease is most commonly diagnosed through a combination of blood tests and imaging, typically an abdominal ultrasound scan. Liver function tests (LFTs) may show raised liver enzymes such as ALT (alanine aminotransferase), though these can be normal even when fatty liver is present.

NICE guidance (NG49) recommends a structured approach to risk stratification. In primary care, a non-invasive scoring tool such as the FIB-4 index or the NAFLD Fibrosis Score is used to identify people at lower or higher risk of advanced fibrosis. Those at higher risk may be referred for second-line testing with the Enhanced Liver Fibrosis (ELF) test, and a FibroScan (transient elastography) may be used to assess liver stiffness.^[3][4] Liver biopsy is reserved for cases where non-invasive tests are inconclusive or where the diagnosis is uncertain. People with suspected advanced fibrosis are referred to hepatology for specialist assessment.

NICE NG49 uses the term non-alcoholic fatty liver disease (NAFLD); the condition is increasingly referred to internationally as metabolic dysfunction-associated steatotic liver disease (MASLD), with MASH replacing NASH for the inflammatory subtype. Both terms refer to the same spectrum of disease.

Management is primarily lifestyle-based and includes:

• Weight loss: A reduction of 7 to 10 per cent or more in body weight has evidence of benefit for reducing liver inflammation and fibrosis

• A balanced diet: A Mediterranean-style dietary pattern, reducing ultra-processed foods, refined carbohydrates and saturated fats, is supported by evidence

• Regular physical activity: Both aerobic exercise and resistance training have evidence of benefit

• Alcohol: UK Chief Medical Officers advise keeping alcohol consumption to no more than 14 units per week for both men and women; your clinician may advise abstinence if you have steatohepatitis or more advanced fibrosis^[14][15]

• Management of associated conditions: Controlling blood glucose, blood pressure and cholesterol; statins are not contraindicated in NAFLD or MASLD and may be prescribed for dyslipidaemia where clinically indicated

At present, there is no MHRA-authorised medicine specifically licensed in the UK for the treatment of NAFLD or MASH as a primary indication, though research in this area is active.^[20][21] Your GP or a hepatology specialist will guide management based on the severity of your condition.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations, with prescriber review and pharmacist support, for those exploring weight management options that may form part of a broader approach to metabolic health. Any prescription medicine would only be considered where clinically appropriate following a consultation.

If you are concerned about your liver health, your GP is the right starting point for assessment and onward referral if needed.

Scientific References

1. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
2. Non-alcoholic fatty liver disease (NAFLD).
3. NG49 – Assessment for advanced liver fibrosis in people with MASLD.
4. NG49 – Recommendations for research.
5. NG49 full guideline PDF – Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management.
6. Gilbert's syndrome.
7. Primary biliary cholangitis – Symptoms.
8. Cholestatic Pruritus: A Review of Pathophysiology, Clinical Features and Management.
9. The Scientific Basis of Cholestatic Liver Disease and Its Symptom Complex. Clinics in Liver Disease.
10. Metabolic syndrome and dyslipidemia in xanthelasma palpebrarum.
11. Evaluation of factors influencing xanthelasma palpebrarum in Chinese patients: A case-control study. Medicine.
12. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Journal of Hepatology.
13. Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction-associated Steatotic Liver Disease: Radiologists' Perspective. Radiographics.
14. Alcohol consumption: advice on low risk drinking – UK Chief Medical Officers.
15. Drink less alcohol – Better Health.
16. Mediterranean diet for the management of metabolic dysfunction-associated steatotic liver disease.
17. Mediterranean and low-fat diets are equally effective in MASLD resolution at 12 weeks regardless of PNPLA3 genotype: A randomized controlled trial. Hepatology Communications.
18. Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in MASLD: a systematic review and meta-analysis of randomized controlled trials. BMC Medicine.
19. Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Frontiers in Nutrition.
20. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.
21. Draft scope post-referral – GID-TA11477 (MASLD/MASH – no approved medicines statement).

Frequently Asked Questions